» Articles » PMID: 23852086

Stereoselective Binding of Chiral Drugs to Plasma Proteins

Overview
Specialty Pharmacology
Date 2013 Jul 16
PMID 23852086
Citations 22
Authors
Affiliations
Soon will be listed here.
Abstract

Chiral drugs show distinct biochemical and pharmacological behaviors in the human body. The binding of chiral drugs to plasma proteins usually exhibits stereoselectivity, which has a far-reaching influence on their pharmacological activities and pharmacokinetic profiles. In this review, the stereoselective binding of chiral drugs to human serum albumin (HSA), α1-acid glycoprotein (AGP) and lipoprotein, three most important proteins in human plasma, are detailed. Furthermore, the application of AGP variants and recombinant fragments of HSA for studying enantiomer binding properties is also discussed. Apart from the stereoselectivity of enantiomer-protein binding, enantiomer-enantiomer interactions that may induce allosteric effects are also described. Additionally, the techniques and methods used to determine drug-protein binding parameters are briefly reviewed.

Citing Articles

Stereoselective Voltammetric Biosensor for Myo-Inositol and D-Chiro-Inositol Recognition.

Tortolini C, Gigli V, Rizzo F, Lenzi A, Bizzarri M, Angeloni A Sensors (Basel). 2023; 23(22).

PMID: 38005597 PMC: 10674735. DOI: 10.3390/s23229211.


Detection and analysis of chiral molecules as disease biomarkers.

Liu Y, Wu Z, Armstrong D, Wolosker H, Zheng Y Nat Rev Chem. 2023; 7(5):355-373.

PMID: 37117811 PMC: 10175202. DOI: 10.1038/s41570-023-00476-z.


Insight into the Interaction Mechanism of HSA with Aztreonam: A Multispectroscopic and Computational Approach.

Sabour A, Khan A, Alhuzani M Molecules. 2022; 27(22).

PMID: 36431957 PMC: 9698515. DOI: 10.3390/molecules27227858.


Analysis of drug interactions with serum proteins and related binding agents by affinity capillary electrophoresis: A review.

Sharmeen S, Kyei I, Hatch A, Hage D Electrophoresis. 2022; 43(23-24):2302-2323.

PMID: 36250426 PMC: 10098505. DOI: 10.1002/elps.202200191.


Organism-specific differences in the binding of ketoprofen to serum albumin.

Czub M, Stewart A, Shabalin I, Minor W IUCrJ. 2022; 9(Pt 5):551-561.

PMID: 36071810 PMC: 9438504. DOI: 10.1107/S2052252522006820.


References
1.
Fitos I, Visy J, Simonyi M . Species-dependency in chiral-drug recognition of serum albumin studied by chromatographic methods. J Biochem Biophys Methods. 2003; 54(1-3):71-84. DOI: 10.1016/s0165-022x(02)00131-8. View

2.
Chuang V, Otagiri M . Stereoselective binding of human serum albumin. Chirality. 2006; 18(3):159-66. DOI: 10.1002/chir.20237. View

3.
Kaneko K, Chuang V, Minomo A, Yamasaki K, Bhagavan N, Maruyama T . Histidine146 of human serum albumin plays a prominent role at the interface of subdomains IA and IIA in allosteric ligand binding. IUBMB Life. 2011; 63(4):277-85. DOI: 10.1002/iub.457. View

4.
Katsuki H, Nakamura C, Arimori K, Fujiyama S, Nakano M . Genetic polymorphism of CYP2C19 and lansoprazole pharmacokinetics in Japanese subjects. Eur J Clin Pharmacol. 1997; 52(5):391-6. DOI: 10.1007/s002280050307. View

5.
Chen J, Hage D . Quantitative studies of allosteric effects by biointeraction chromatography: analysis of protein binding for low-solubility drugs. Anal Chem. 2006; 78(8):2672-83. PMC: 2556871. DOI: 10.1021/ac052017b. View